Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Nova Eye Medical (AU:EYE)
ASX:EYE
Nova Eye Medical (EYE) Share Price & Analysis
8 Followers
EYE Stock Chart & Stats
Day’s RangeAU$0 - AU$0
52-Week RangeAU$0.11 - AU$0.32
Previous CloseAU$0.25
Volume131.95K
Average Volume (3M)599.88K
Market Cap
AU$57.21M
Enterprise ValueAU$51.15M
Total Cash (Recent Filing)AU$8.00M
Total Debt (Recent Filing)AU$1.94M
Price to Earnings (P/E)―
Beta-0.07
Next Earnings
Aug 28, 2024EPS EstimateN/A
Last Dividend Ex-Date
Jul 21, 2020Dividend YieldN/A
Share Statistics
EPS (TTM)-0.08
Shares Outstanding228,797,274
10 Day Avg. Volume105,890
30 Day Avg. Volume599,885
Standard Deviation0.19
R-Squared0.09
Alpha0.02
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Nova Eye Medical News
PremiumCompany Announcements
Nova Eye Medical’s Glaucoma Sales SoarPremiumCompany Announcements
Nova Eye Medical’s Impressive Sales Growth
PremiumCompany Announcements
Nova Eye Medical Unaffected by Proposed Medicare Changes
PremiumCompany Announcements
Nova Eye Medical Expands Share QuotationsOptions Prices
Currently, No data available
---
Ownership Overview
7.56% Insiders
0.00% Mutual Funds
0.00% Other Institutional Investors
92.44% Public Companies and
Individual Investors
EYE FAQ
What was Nova Eye Medical’s price range in the past 12 months?
Nova Eye Medical lowest share price was AU$0.11 and its highest was AU$0.32 in the past 12 months.
What is Nova Eye Medical’s market cap?
Currently, no data Available
When is Nova Eye Medical’s upcoming earnings report date?
Nova Eye Medical’s upcoming earnings report date is Aug 28, 2024 which is in 36 days.
How were Nova Eye Medical’s earnings last quarter?
Nova Eye Medical released its earnings results on Feb 22, 2024. The company reported -AU$0.03 earnings per share for the quarter, missing the consensus estimate of N/A by -AU$0.03.
Is Nova Eye Medical overvalued?
According to Wall Street analysts Nova Eye Medical’s price is currently Overvalued.
Does Nova Eye Medical pay dividends?
Nova Eye Medical pays a Notavailable dividend of AU$0.14 which represents an annual dividend yield of N/A. See more information on Nova Eye Medical dividends here
What is Nova Eye Medical’s EPS estimate?
Nova Eye Medical’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Nova Eye Medical have?
Nova Eye Medical has 228,823,270 shares outstanding.
What happened to Nova Eye Medical’s price movement after its last earnings report?
Nova Eye Medical reported an EPS of -AU$0.03 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Nova Eye Medical?
Currently, no hedge funds are holding shares in AU:EYE
---
Nova Eye Medical Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
0.00%
12-Months-Change
Fundamentals
Return on Equity
-67.02%
Trailing 12-Months
Asset Growth
-22.69%
Trailing 12-Months
Company Description
Nova Eye Medical
Ellex Medical Lasers Ltd. engages in design and manufacture of ophthalmic laser and ultrasound systems used by ophthalmologists to diagnose and treat eye diseases. It operates through the following segments: Faster Growing (iTrack), Emerging (2RT), and Core Ophthalmic Mark (Lasers and Ultrasounds). The iTrack segment offers catheter device that dilates the ocular structures compromised by glaucoma. The 2RT segment includes patent-protected with significant lead on competition and a per-use recurring fee business model. The Lasers and Ultrasounds segment represents testimony to the strength of the Ellex brand and was driven by growth in sales of the high-margin Ellex Tango and Ellex Tango Reflex glaucoma lasers. The company was founded by Giuseppe Canala and Victor Previn in 1985 and is headquartered in Adelaide, Australia.
---
Technical Analysis
Nova Eye Medical
―
Novartis
―
Bausch Health Companies
―
Alimera
―
Kala Pharmaceuticals
―
---